[18f]f-ara-g
Showing 1 - 2 of 2
GVHD Trial in Stanford ([18F]F-Ara-G)
Recruiting
- Graft Versus Host Disease
- [18F]F-Ara-G
-
Stanford, CaliforniaStanford Hospital
Mar 7, 2022
NSCLC Trial ([18F]F-Ara-G, Pembrolizumab, PET/CT scan)
Withdrawn
- Non-small Cell Lung Cancer
- [18F]F-Ara-G
- +2 more
- (no location specified)
Oct 17, 2019